{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:56:19Z","timestamp":1790193379359,"version":"4.1.0"},"reference-count":41,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cla Caixa\u201d Foundation","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"\u201cla Caixa\u201d Foundation","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"\u201cla Caixa\u201d Foundation","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"\u201cla Caixa\u201d Foundation","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Sara Borrell","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"Sara Borrell","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"Sara Borrell","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"Sara Borrell","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Novo Nordisk New Investigator Award in Basic Sciences 2023","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"Novo Nordisk New Investigator Award in Basic Sciences 2023","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"Novo Nordisk New Investigator Award in Basic Sciences 2023","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"Novo Nordisk New Investigator Award in Basic Sciences 2023","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"EFSD\/Lilly Young Investigator Award 2022","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"EFSD\/Lilly Young Investigator Award 2022","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"EFSD\/Lilly Young Investigator Award 2022","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"EFSD\/Lilly Young Investigator Award 2022","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Society for Endocrinology\/Early Career Grant 2022","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"Society for Endocrinology\/Early Career Grant 2022","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"Society for Endocrinology\/Early Career Grant 2022","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"Society for Endocrinology\/Early Career Grant 2022","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"FSEEN\/J\u00f3venes endocrin\u00f3logos 2022","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"FSEEN\/J\u00f3venes endocrin\u00f3logos 2022","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"FSEEN\/J\u00f3venes endocrin\u00f3logos 2022","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"FSEEN\/J\u00f3venes endocrin\u00f3logos 2022","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Instituto de Salud Carlos III (ISCIII)","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"Instituto de Salud Carlos III (ISCIII)","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"Instituto de Salud Carlos III (ISCIII)","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"Instituto de Salud Carlos III (ISCIII)","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n (MCIN)","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n (MCIN)","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n (MCIN)","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n (MCIN)","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]},{"name":"MICIN\/AEI","award":["LCF\/BQ\/DR21\/11880010"],"award-info":[{"award-number":["LCF\/BQ\/DR21\/11880010"]}]},{"name":"MICIN\/AEI","award":["CD19\/00078"],"award-info":[{"award-number":["CD19\/00078"]}]},{"name":"MICIN\/AEI","award":["NNF23SA0083952"],"award-info":[{"award-number":["NNF23SA0083952"]}]},{"name":"MICIN\/AEI","award":["CEX2020-001041-S"],"award-info":[{"award-number":["CEX2020-001041-S"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>As the global obesity rate increases, so does the urgency to find effective anti-obesity drugs. In the search for therapeutic targets, central nervous system (CNS) mechanisms engaged in the regulation of energy expenditure and food intake, such as the opioid and dopamine systems, are crucial. In this study, we examined the effect on body weight of two drugs: bromocriptine (BC), a D2R receptor agonist, and PF-04455242, a selective \u03ba opioid receptor (KOR) antagonist. Using diet-induced obese (DIO) rats, we aimed to ascertain whether the administration of BC and PF-04455242, independently or in combination, could enhance body weight loss. Furthermore, the present work demonstrates that the peripheral coadministration of BC and PF-04455242 enhances the reduction of weight in DIO rats and leads to a decrease in adiposity in a food-intake-independent manner. These effects were based on heightened energy expenditure, particularly through the activation of brown adipose tissue (BAT) thermogenesis. Overall, our findings indicate that the combination of BC and PF-04455242 effectively induces body weight loss through increased energy expenditure by increasing thermogenic activity and highlight the importance of the combined use of drugs to combat obesity.<\/jats:p>","DOI":"10.3390\/nu16030424","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T09:56:34Z","timestamp":1706694994000},"page":"424","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Combination of a Dopamine Receptor 2 Agonist and a Kappa Opioid Receptor Antagonist Synergistically Reduces Weight in Diet-Induced Obese Rodents"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-5185","authenticated-orcid":false,"given":"Beatriz","family":"Cicu\u00e9ndez","sequence":"first","affiliation":[{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9942-7160","authenticated-orcid":false,"given":"Javier","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-9149","authenticated-orcid":false,"given":"Cintia","family":"Folgueira","sequence":"additional","affiliation":[{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,31]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020, April 01). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1592\/phco.20.4.270.34882","article-title":"Orlistat, a new lipase inhibitor for the management of obesity","volume":"20","author":"Heck","year":"2000","journal-title":"Pharmacotherapy"},{"key":"ref_4","first-page":"e29262","article-title":"FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade","volume":"14","author":"Idrees","year":"2022","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s42255-023-00812-z","article-title":"Gut hormone co-agonists for the treatment of obesity: From bench to bedside","volume":"5","author":"Nogueiras","year":"2023","journal-title":"Nat. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13098-021-00733-5","article-title":"The best drug supplement for obesity treatment: A systematic review and network meta-analysis","volume":"13","author":"Salari","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of Subcutaneous Semaglutide vs. Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity: The STEP 3 Randomized Clinical Trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/HJH.0000000000000145","article-title":"Cardiovascular effects of phentermine and topiramate: A new drug combination for the treatment of obesity","volume":"32","author":"Jordan","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000335352","article-title":"Naltrexone\/bupropion: An investigational combination for weight loss and maintenance","volume":"4","author":"Makowski","year":"2011","journal-title":"Obes. Facts"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s42255-019-0099-7","article-title":"Hypothalamic dopamine signaling regulates brown fat thermogenesis","volume":"1","author":"Folgueira","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(00)03643-6","article-title":"Brain dopamine and obesity","volume":"357","author":"Wang","year":"2001","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2337\/diacare.23.8.1154","article-title":"Bromocriptine: A novel approach to the treatment of type 2 diabetes","volume":"23","author":"Pijl","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1463-1326.2010.01304.x","article-title":"Bromocriptine: Old drug, new formulation and new indication","volume":"12","author":"Holt","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diacare.19.6.667","article-title":"Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects","volume":"19","author":"Cincotta","year":"1996","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1054\/npep.1999.0050","article-title":"Opioids and food intake: Distributed functional neural pathways?","volume":"33","author":"Glass","year":"1999","journal-title":"Neuropeptides"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"170752","DOI":"10.1016\/j.peptides.2022.170752","article-title":"Endogenous opiates and behavior: 2020","volume":"151","author":"Bodnar","year":"2022","journal-title":"Peptides"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: Drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1210\/me.2006-0367","article-title":"Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice","volume":"21","author":"Sainsbury","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1096\/fj.09-143610","article-title":"kappa-Opioid receptors control the metabolic response to a high-energy diet in mice","volume":"24","author":"Czyzyk","year":"2010","journal-title":"FASEB J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/npp.2013.28","article-title":"Hypothalamic kappa-opioid receptor modulates the orexigenic effect of ghrelin","volume":"38","author":"Vazquez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2017.11.040","article-title":"Melanin-Concentrating Hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake","volume":"130","author":"Imbernon","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1038\/s41467-019-12004-z","article-title":"Central nicotine induces browning through hypothalamic kappa opioid receptor","volume":"10","author":"Morgan","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Romero-Pico, A., Novelle, M.G., Al-Massadi, O., Beiroa, D., Tojo, M., Heras, V., Ruiz-Pino, F., Senra, A., Lopez, M., and Blouet, C. (2022). Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063118"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.111.185108","article-title":"Pharmacological characterization of 2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for kappa-opioid receptors","volume":"339","author":"Grimwood","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e13008","DOI":"10.1111\/apha.13008","article-title":"Cooperative role of the glucagon-like peptide-1 receptor and beta3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA\/AKT\/AMPK signalling in the adipose tissue and muscle of rats","volume":"222","author":"Decara","year":"2018","journal-title":"Acta Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2337\/db15-0889","article-title":"Uroguanylin Action in the Brain Reduces Weight Gain in Obese Mice via Different Efferent Autonomic Pathways","volume":"65","author":"Folgueira","year":"2016","journal-title":"Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s42255-022-00602-z","article-title":"Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21","volume":"4","author":"Folgueira","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/hep.28716","article-title":"Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone-induced liver damage through inflammation and endoplasmic reticulum stress","volume":"64","author":"Imbernon","year":"2016","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0091-3057(88)90391-7","article-title":"Multiple brain sites sensitive to feeding stimulation by opioid agonists: A cannula-mapping study","volume":"31","author":"Stanley","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/mcne.1994.1063","article-title":"G protein-activated inwardly rectifying potassium channel (GIRK1\/KGA) mRNA in adult rat heart and brain by in situ hybridization histochemistry","volume":"5","author":"DePaoli","year":"1994","journal-title":"Mol. Cell Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.2337\/diabetes.54.12.3510","article-title":"Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: Evidence for a \u201cthrifty gene\u201d","volume":"54","author":"Tabarin","year":"2005","journal-title":"Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(93)91552-4","article-title":"The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding","volume":"631","author":"Kotz","year":"1993","journal-title":"Brain Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-8993(93)90493-7","article-title":"The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat","volume":"629","author":"Lambert","year":"1993","journal-title":"Brain Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"R814","DOI":"10.1152\/ajpregu.2001.280.3.R814","article-title":"Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection","volume":"280","author":"Hagan","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/npp.2017.133","article-title":"kappa-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition","volume":"43","author":"Abraham","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"108341","DOI":"10.1016\/j.neuropharm.2020.108341","article-title":"Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis","volume":"181","author":"Pirino","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2020.00057","article-title":"Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors","volume":"11","author":"Escobar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0253-7613.56070","article-title":"Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes","volume":"41","author":"Mahajan","year":"2009","journal-title":"Indian J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejmech.2017.10.012","article-title":"Selective kappa opioid antagonists for treatment of addiction, are we there yet?","volume":"141","author":"Helal","year":"2017","journal-title":"Eur. J. Med. Chem."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/3\/424\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:52:17Z","timestamp":1760104337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/3\/424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["nu16030424"],"URL":"https:\/\/doi.org\/10.3390\/nu16030424","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]}}}